Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is Rp 2.044.669,45, with a 24-hour trading volume of Rp 7,87T. The asset's market cap is Rp 5,05P, after moving 2.60% in the last day.
Tokenized Merck & Co Inc is trading at Rp 2.046.384,99, with a tokenized market cap of Rp 14,8B and a 24-hour trading volume of Rp 17,81B. The tokenized asset has moved -2.59% in the past 24 hours.